Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Pinto bean supplementation prevents vascular dysfunction by modulating the gut microbiome in an interleukin-10-dependent manner in mice fed an atherogenic diet

1 month ago
The risk of cardiovascular disease increases under gut inflammatory conditions, but the underlying mechanism remains unclear. Pinto bean (PB) consumption reportedly increases the ileal expression of the anti-inflammatory cytokine interleukin (IL)-10. We investigated the effects of PB supplementation on inflammatory signature and vascular endothelial function in mice. We hypothesize that the effect of PB is mainly mediated by IL-10. Eight-week-old female mice from a C57BL/6 J background were...
Sanmi E Alake

Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025

1 month ago
CONCLUSIONS: Cannabis retailer frequently made prohibited health claims and minimized risks, reinforcing public health concerns and the need for ongoing cannabis retail surveillance and stronger regulatory oversight and enforcement.
Carla J Berg

PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes

1 month ago
CONCLUSIONS: In the largest synthesis of rechallenge strategies to date, PD-(L)1 rechallenge produced statistically significant but clinically marginal improvements in OS and PFS compared with standard treatments, with no benefit in patients with primary resistance. A signal of benefit was observed in patients with acquired resistance to prior immunotherapy although this exploratory analysis was limited by heterogeneous resistance definitions across trials and a non-significant interaction test.
Daniele Marinelli

Compound Heterozygote Friedreich Ataxia Patients With Covert Proximal FXN Gene Deletions

1 month ago
We present Friedreich ataxia patients with frataxin gene deletions. Data and records were collected at the Children's Hospital of Philadelphia from patients enrolled in the FACOMS natural history study. Patients with proximal deletions initially diagnosed with only one GAA expanded allele had more severe disease than their homozygous expansion counterparts, including increased frequency of cardiomyopathy, diabetes, and optic neuropathy. Their phenotypes were like those of individuals with distal...
Michael P Lazaropoulos

Using Open-Window Mapping Strategy for Wolff-Parkinson-White Syndrome in a Patient With Dextrocardia With Situs Inversus

1 month ago
The coexistence of dextrocardia and Wolff-Parkinson-White (WPW) syndrome is exceedingly rare and presents unique challenges for electrophysiological mapping and ablation. We report the first successful radiofrequency catheter ablation guided by three-dimensional open-window mapping (OWM) in such a patient. Pre-procedural right-sided electrocardiography analyzed with the EASY-WPW algorithm predicted a right inferoparaseptal accessory pathway, consistent with OWM localization. Despite reversed...
Ding-Sen Huang

Pagination

  • Previous page ‹ Previous
  • Page 159
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies